MedicalXpress reports that in the period of 1995 to 2015, China saw remarkable progress in diabetes research, according to a study recently published by Science China Life Sciences.
During the past two decades, as China experienced unprecedented economic growth, non-communicable diseases such as diabetes reached epidemic proportions, potentially owing to the combination of increased life expectancy and unhealthy lifestyles. The prevalence of diabetes has increased dramatically from 0.67 percent in 1980 to 2.51 percent in 1994 and to 10.9 percent in 2013; China now has the largest number of diabetes patients worldwide. This number continues to grow and puts ongoing strains on medical resources. Therefore, there is an urgent need to stop the diabetes epidemic and slow down the progression of diabetic complications.
A research group led by Jianping Weng at the Third Affiliated Hospital of Sun Yat-sen University in Guangzhou reviewed all diabetes research studies conducted in China between 1995 and 2015, and scrutinized the publication number, publication influence, progress, and unmet demands of diabetes research in China.
According to the bibliometric analysis in the study, diabetes research in China has progressed remarkably over the past two decades. Consistent with the rapid growth in China’s gross domestic product (GDP), scientific research funds have surged during the same period. The increase in the investment in science has contributed to the tremendous growth in the number of diabetes publications (Figure 1). The progress can not only be identified in quantity, but in publication influence when analyzing by journal distribution, by citation number and by publications cited by the guidelines. The total citation number and citation number per publication of diabetes publications has been on the rise in the past two decades; moreover, this trend is predicted to persist at least until 2020